Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity

Liudmila Kulakova(Advanced Bioscience Laboratories (United States)), Thomas R. Fuerst(University of Maryland, Baltimore), Alexander Marin(Advanced Bioscience Laboratories (United States)), Stephanie Archer‐Hartmann(University of Georgia), Austin W.T. Chiang(Foundation Center), Saori Suzuki(Hokkaido University of Science), Salman Shahid(Advanced Bioscience Laboratories (United States)), Eric A. Toth(Institute for Bioscience and Biotechnology Research), Bhoj Kumar(University of Georgia), Sanne Schoffelen(Novo Nordisk Foundation), Khadija Elkholy(National Research Centre), Parastoo Azadi(University of Georgia), Nathan E. Lewis(University of Georgia), Kinlin Chao(National Institute of Standards and Technology), Michael P. Schwoerer(Princeton University), Roy A. Mariuzza(Advanced Bioscience Laboratories (United States)), Björn G. Voldborg(Novo Nordisk Foundation), Alexander Ploß(Rockefeller University), Alexander K. Andrianov(Advanced Bioscience Laboratories (United States)), Nathan B. Murray(University of Georgia), K. Li(University of San Diego)
npj Vaccines
June 11, 2025
Cited by 7


Related Papers